Asia Pac Allergy.  2013 Apr;3(2):120-126. 10.5415/apallergy.2013.3.2.120.

Staphylococcal enterotoxin specific IgE and asthma: a systematic review and meta-analysis

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. addchang@snu.ac.kr
  • 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea.
  • 3Department of Internal Medicine, Pusan National University College of Medicine, Busan 602-739, Korea.
  • 4Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea.

Abstract

BACKGROUND
Recent literature suggests that Staphylococcal enterotoxin specific IgE may be a risk factor for asthma.
OBJECTIVE
To investigate the associations between Staphylococcal enterotoxin sensitization and asthma.
METHODS
A systematic review and meta-analysis was performed for relevant case-control or population-based studies, published in the peer-reviewed journals until February 2013. Data were extracted on study designs, subjects, definitions and the prevalence of Staphylococcal enterotoxin sensitization.
RESULTS
A total of 683 studies were initially identified, of which 7 studies finally met the inclusion criteria (5 case-control and 2 population-based studies). All the included studies reported higher prevalence of the sensitization in asthmatics than in controls, despite clinical and methodological heterogeneity. In a meta-analysis, the pooled odds ratio of the sensitization for asthma was 2.95 (95% confidence intervals 2.28-3.82).
CONCLUSION
Staphylococcal enterotoxin sensitization was significantly associated with asthma. The mechanisms of associations warrant further elucidation.

Keyword

Asthma; Staphylococcus; Meta-analysis

MeSH Terms

Asthma*
Case-Control Studies
Enterotoxins*
Immunoglobulin E*
Odds Ratio
Population Characteristics
Prevalence
Risk Factors
Staphylococcus
Enterotoxins
Immunoglobulin E

Figure

  • Fig. 1 Flowchart for the identification of relevant studies.

  • Fig. 2 Forest plots of studies comparing the frequency of Staphylococcal enterotoxin sensitization in asthmatics and controls. Green squares represent individual studies, and the size of squares is proportional to the number of subjects in the study. Horizontal lines indicate 95% confidence interval ranges. Vertical dotted lines and diamond shapes represent pooled summary estimates for the analysis (the width of the diamond represents the 95% CI).OR, odds ratio; 95% CI, 95% confidence interval; M-H, Mantel-Haenzel test; D+L, DerSimonian and Laird method.


Reference

1. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008; 372:1107–1119. PMID: 18805339.
Article
2. Heederik D, von Mutius E. Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma? J Allergy Clin Immunol. 2012; 130:44–50. PMID: 22502794.
Article
3. Brooks C, Pearce N, Douwes J. The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol. 2013; 13:70–77. PMID: 23103806.
4. Wilson M. Bacteriology of humans: an ecological perspective. 2008. Malden, MA: Wiley-Blackwell.
5. Bachert C, Gevaert P, van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy. 2002; 57:480–487. PMID: 12028112.
Article
6. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125:4–13. PMID: 20109729.
Article
7. Bachert C, Zhang N, Patou J, van Zele T, Gevaert P. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol. 2008; 8:34–38. PMID: 18188015.
Article
8. Bachert C, van Steen K, Zhang N, Holtappels G, Cattaert T, Maus B, Buhl R, Taube C, Korn S, Kowalski M, Bousquet J, Howarth P. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol. 2012; 130:376–381.e8. PMID: 22738677.
Article
9. Kowalski ML, Cieślak M, Pérez-Novo CA, Makowska JS, Bachert C. Clinical and immunological determinants of severe/refractory asthma (SRA): association with staphylococcal superantigen-specific IgE antibodies. Allergy. 2011; 66:32–38. PMID: 20973803.
Article
10. Pastacaldi C, Lewis P, Howarth P. Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta-analysis. Allergy. 2011; 66:549–555. PMID: 21087214.
Article
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6:e1000100. PMID: 19621070.
Article
12. Hollams EM, Hales BJ, Bachert C, Huvenne W, Parsons F, de Klerk NH, Serralha M, Holt BJ, Ahlstedt S, Thomas WR, Sly PD, Holt PG. Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur Respir J. 2010; 36:509–516. PMID: 20110393.
Article
13. Semic-Jusufagic A, Bachert C, Gevaert P, Holtappels G, Lowe L, Woodcock A, Simpson A, Custovic A. Staphylococcus aureus sensitization and allergic disease in early childhood: population-based birth cohort study. J Allergy Clin Immunol. 2007; 119:930–936. PMID: 17292957.
Article
14. Lee JY, Kim HM, Ye YM, Bahn JW, Suh CH, Nahm D, Lee HR, Park HS. Role of staphylococcal superantigen-specific IgE antibodies in aspirin-intolerant asthma. Allergy Asthma Proc. 2006; 27:341–346. PMID: 17063661.
Article
15. Lee JH, Lin YT, Yang YH, Wang LC, Chiang BL. Increased levels of serum-specific immunoglobulin e to staphylococcal enterotoxin a and B in patients with allergic rhinitis and bronchial asthma. Int Arch Allergy Immunol. 2005; 138:305–311. PMID: 16224190.
Article
16. Rossi RE, Monasterolo G. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol. 2004; 133:261–266. PMID: 14976395.
17. Tee RD, Pepys J. Specific serum IgE antibodies to bacterial antigens in allergic lung disease. Clin Allergy. 1982; 12:439–450. PMID: 6982789.
Article
18. Walker IC, Adkinson J. Study XIII: the relationship between the Cutaneous Reaction, Serum Agglutination Tests and Bacteriological Examination of the Sputum and Nasal Secretions in determining the part Staphylococcus Pyogenes Aureus and Albus may play in the cause of Bronchial Asthma. J Med Res. 1917; 36:295–308. PMID: 19972369.
19. Virtue CM, Wittig HJ, Cook TJ. Lymphocyte transformation with bacterial antigens in intrinsic asthma. J Allergy Clin Immunol. 1971; 48:321–330. PMID: 4399176.
Article
20. Bacigaluppi JE, Negroni R, de Severino HM. Bacterial allergy in allergic rhinitis and bronchial asthma. Ann Allergy. 1979; 42:95–98. PMID: 33586.
21. Alam R, Kuna P, Rozniecki J, Kuzminska B. Bacterial antigens stimulate the production of histamine releasing factor (HRF) by lymphocytes from intrinsic asthmatic patients. Clin Exp Immunol. 1986; 63:241–248. PMID: 2420497.
22. Beklemishev ND, Belyaev NN, Sukhodoeva GS, Bulvakhter YL. The mechanisms of bronchospasm in experimental microbial sensitization. I. Immunological stage. Allergol Immunopathol (Madr). 1984; 12:129–134. PMID: 6464938.
23. del Real Sánchez JH. Controversy in asthma. I. Staphylococcus aureus as the main factor responsible for bronchospasm. Rev Alerg Mex. 1987; 34:89–97. PMID: 3324813.
24. Brarda OA, Vanella LM, Boudet RV. Anti-Staphylococcus aureus, anti-Streptococcus pneumoniae and anti-Moraxella catarrhalis specific IgE in asthmatic children. J Investig Allergol Clin Immunol. 1996; 6:266–269.
25. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol. 2000; 105:782–787. PMID: 10756230.
Article
26. Mandron M, Ariès MF, Brehm RD, Tranter HS, Acharya KR, Charveron M, Davrinche C. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 cell polarization. J Allergy Clin Immunol. 2006; 117:1141–1147. PMID: 16675344.
Article
27. Huvenne W, Callebaut I, Reekmans K, Hens G, Bobic S, Jorissen M, Bullens DM, Ceuppens JL, Bachert C, Hellings PW. Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy. 2010; 65:1013–1020. PMID: 20132156.
Article
28. Huvenne W, Callebaut I, Plantinga M, Vanoirbeek JA, Krysko O, Bullens DM, Gevaert P, Van Cauwenberge P, Lambrecht BN, Ceuppens JL, Bachert C, Hellings PW. Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy. 2010; 40:1079–1090. PMID: 20214664.
Article
29. Herz U, Rückert R, Wollenhaupt K, Tschernig T, Neuhaus-Steinmetz U, Pabst R, Renz H. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness---a model for non-allergic asthma. Eur J Immunol. 1999; 29:1021–1031. PMID: 10092107.
30. Yu J, Oh MH, Park JU, Myers AC, Dong C, Zhu Z, Zheng T. Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS One. 2012; 7:e39032. PMID: 22848348.
Article
31. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. Disordered microbial communities in asthmatic airways. PLoS One. 2010; 5:e8578. PMID: 20052417.
Article
32. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011; 127:372–381.e1-3. PMID: 21194740.
Article
33. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol. 2008; 181:3733–3739. PMID: 18768823.
Article
34. Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy. 2010; 65:1430–1437. PMID: 20456313.
Article
35. Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy. 2009; 23:461–465. PMID: 19807976.
Article
36. Hauk PJ, Wenzel SE, Trumble AE, Szefler SJ, Leung DY. Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. J Allergy Clin Immunol. 1999; 104:37–45. PMID: 10400837.
37. Losol P, Kim SH, Hwang EK, Shin YS, Park HS. IL-5 Promoter polymorphism enhances IgE responses to staphylococcal superantigens in adult asthmatics. Allergy Asthma Immunol Res. 2013; 5:106–109. PMID: 23449963.
38. Kim MR, Hong SW, Choi EB, Lee WH, Kim YS, Jeon SG, Jang MH, Gho YS, Kim YK. Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses. Allergy. 2012; 67:1271–1281. PMID: 22913540.
Article
39. Ross MA, Curtis L, Scheff PA, Hryhorczuk DO, Ramakrishnan V, Wadden RA, Persky VW. Association of asthma symptoms and severity with indoor bioaerosols. Allergy. 2000; 55:705–711. PMID: 10955695.
Article
Full Text Links
  • APA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr